The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2024

Filed:

Sep. 24, 2019
Applicants:

Centre National DE LA Recherche Scientifique, Paris, FR;

Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;

Inventors:

Liliane Massade, Cachan, FR;

Charbel Massaad, Arcueil, FR;

Susan Boutary, Arcueil, FR;

Giorgia Maria Laura Urbinati, Paris, FR;

Patrick Couvreur, Paris, FR;

Didier Desmaële, Fresnes, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 9/51 (2006.01); A61K 45/06 (2006.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 9/5123 (2013.01); A61K 45/06 (2013.01); A61K 47/6929 (2017.08); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/351 (2013.01); C12N 2320/32 (2013.01);
Abstract

The present invention relates to antisense RNAs targeting PMP22 and able to inhibit from 40% to 60% the expression of PMP22 in the cells and a pharmaceutical composition comprising thereof. The antisense RNAs are preferably siRNA and are preferably provided in the form of nanoparticles. The present invention also relates to the use of these antisense RNAs targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease.


Find Patent Forward Citations

Loading…